Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard S Finn

Showing results (11-20 of 240) with videos related to

Pageof 24
Sort By:
Gastroenterology & Hepatology|December 6, 2016
The Role of Liver Biopsy in Hepatocellular CarcinomaRichard S Finn
Liver Cancer|October 26, 2013
Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR InhibitionRichard S Finn
Journal of Hepatology|April 4, 2019
Progression-free survival: Starting point or endpoint in advanced HCC trial design?Richard S Finn
Journal of Hepatology|November 13, 2013
Survival after sorafenib: expect the unexpectedRichard S Finn
Liver Cancer|August 6, 2016
Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionBingnan Zhang, Richard S Finn
Clinical Liver Disease|September 12, 2019
The Place of Novel Therapies in the American Association for the Study of Liver Diseases Guidelines for Hepatocellular CarcinomaAnthony Bejjani, Richard S Finn
Journal of Hepatology|June 28, 2014
Systemic therapy in HCC: lessons from brivanibDavid Bolos, Richard S Finn
Surgical Oncology Clinics of North America|November 9, 2023
Evolution of Systemic Therapy in Advanced Hepatocellular CarcinomaAnthony Bejjani, Richard S Finn
Future Oncology (London, England)|October 4, 2012
Brivanib: a review of developmentTina Chou, Richard S Finn
Hepatic Oncology|September 8, 2018
<i>Hepatic Oncology</i>: a journal for all stakeholders in liver cancer managementRichard S Finn, Jordi Bruix
Pageof 24

Showing results (11-20 of 240) with videos related to

Sort By:
Pageof 24
Gastroenterology & Hepatology|December 6, 2016
The Role of Liver Biopsy in Hepatocellular CarcinomaRichard S Finn
Liver Cancer|October 26, 2013
Current and Future Treatment Strategies for Patients with Advanced Hepatocellular Carcinoma: Role of mTOR InhibitionRichard S Finn
Journal of Hepatology|April 4, 2019
Progression-free survival: Starting point or endpoint in advanced HCC trial design?Richard S Finn
Journal of Hepatology|November 13, 2013
Survival after sorafenib: expect the unexpectedRichard S Finn
Liver Cancer|August 6, 2016
Personalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionBingnan Zhang, Richard S Finn
Clinical Liver Disease|September 12, 2019
The Place of Novel Therapies in the American Association for the Study of Liver Diseases Guidelines for Hepatocellular CarcinomaAnthony Bejjani, Richard S Finn
Journal of Hepatology|June 28, 2014
Systemic therapy in HCC: lessons from brivanibDavid Bolos, Richard S Finn
Surgical Oncology Clinics of North America|November 9, 2023
Evolution of Systemic Therapy in Advanced Hepatocellular CarcinomaAnthony Bejjani, Richard S Finn
Future Oncology (London, England)|October 4, 2012
Brivanib: a review of developmentTina Chou, Richard S Finn
Hepatic Oncology|September 8, 2018
<i>Hepatic Oncology</i>: a journal for all stakeholders in liver cancer managementRichard S Finn, Jordi Bruix
Pageof 24